medical innovation

Eradicating disease seems like an elusive pipe dream but not if you ask Donna Cryer , president and CEO of the Global Liver Institute. “9,000 days ago, doctors told me I had seven days to live,” said Cryer. “I believe in our ability to continually adapt and innovate and conquer disease”. Cryer was joined by Research!America board member Dr. William Hait, global head, Janssen Research and Development, and fellow board member Dr. Mark McClellan, director, Duke-Robert J. Margolis Center for Health Policy, Duke University for an interactive panel discussion titled, A World Without Disease: Can We Get There? , at the BIO International Conference in San Diego, California on June 20. Research!...
Research!America will host an interactive panel discussion on June 20 titled, A World Without Disease: Can We Get There? , at the BIO International Convention in San Diego, California. During the session, experts from the regulatory, pharmaceutical, and advocacy sectors will discuss the implications of new technologies and the challenges of leveraging limited resources to maximize patient benefit. Research!America’s session will seek to address the question, “how can we capitalize on insights from the biotechnology industry and facilitate a coordinated effort to eradicate disease?”. To do so, Research!America board member William Hait, M.D., Ph.D. , global head at Janssen Research and...
Dear Research Advocate, I have exciting news! Joe Biden, the 47th Vice President of the United States, will join us at our 21st Annual Advocacy Awards Dinner on March 15 to receive the Gordon and Llura Gund Leadership Award . As he has demonstrated through his leadership of the Cancer Moonshot Initiative, his work in Congress, and in so many other ways, the former Vice President is a true advocate for research. Join us for a remarkable evening. A foundational goal for this annual event is to spotlight advocates for science -- often those who both practice and champion it -- as embodying the “secret sauce” that empowers science by driving public and policymaker support. More scientists are...
Dear Research Advocate, In his inaugural address President Trump spoke of ushering in a “new millennium” to “unlock the mysteries of space, to free the earth from the miseries of disease, and to harness the energies, industries and technologies of tomorrow.” We’re all in on those goals, to be sure. The President has been very active on many of his campaign pledges during his first week in office, but science hasn’t been a driving theme as yet. However, some of his administration’s actions this week have alarmed members of the science community. It is a time for gatherings in our nation’s capital -- for the Inauguration, for and against the anniversary of Roe v. Wade and more. It’s our...
Dear Research Advocate: As America rings in the New Year, many of us will be reflecting on the past and making resolutions for the future. To get a feel for the numerous ways in which NIH, CDC, AHRQ, NSF and FDA contributed to the well-being of Americans and others throughout the world in 2014, click here . I hope lawmakers are taking time now to establish New Year’€™s resolutions and set priorities for the new Congress, which convenes one week from today. My biggest wish for the new Congress? Pragmatism over politics. If pragmatism rules, the next Congress will shake off the stultifying complacency that is weighing our nation down and act to reignite U.S. innovation. More here . One reason...
November 20, 2014 Congressman Tom Cole’s leadership on the Labor-HHS-Education subcommittee will help shape our ability to sustain and accelerate medical innovation as we confront health crises here and abroad. As a steward of the federal funding that lays the noncommercial foundation for private sector medical progress, Congressman Cole will play a pivotal role in determining whether our nation conquers Alzheimer’s, childhood cancer, Ebola and other insidious health threats. We commend his efforts to ensure quality health care for veterans, remove barriers to innovation through the repeal of the medical device tax and advance other health and research-related initiatives. We look forward...
Research!America salutes Board of Directors Chair John Edward Porter, the 2014 recipient of the Public Welfare Medal from the National Academy of Sciences (NAS), the Academy’€™s most prestigious award to honor the extraordinary use of science for the public good. Porter’€™s leadership in advocacy for research has strengthened our nation’€™s global competitiveness in science and technology and advanced medical innovation to new heights. As chair of the House Appropriations Subcommittee on Labor, Health and Human Services, and Education, Porter demonstrated tremendous foresight, calling on policymakers to support robust investments in research to improve quality of life, combat debilitating...
Dear Research Advocate: The budget and appropriations process typically reveals stark differences in funding priorities among the two parties. And this year is no exception. House Budget Committee Ranking Member Chris Van Hollen (D-MD-08) introduced the Democrats’€™ 10-year budget plan this week, which stands apart from the Republican proposal introduced by Chairman Paul Ryan (R-WI-01) most notably by ending sequestration. The Ryan budget, which won House approval today, is on its way to the Senate but is considered dead on arrival. Note that there’€™s still time to urge your Members of Congress to support medical and health research as this year’€™s appropriations process continues! Teen...
Dear Research Advocate: It has been a week since the Budget Conference Committee’€™s first meeting. The next public meeting is scheduled for November 13. Staffs are at work, and various Members are talking. There are no concrete signs of progress. What I keep coming back to is the failure of our nation’€™s decision makers to recognize and act on the reality that the priorities of Americans are reflected in both discretionary and entitlement programs. The persistence of sequestration underscores Congress’€™ inability to make decisions and choose priorities. The sequestration era has run its course, dealing Congress record lows in terms of public support; it’€™s past time to end the era and...
Next Monday, October 21 at 9:00 pm EST, HBO will debut LIFE ACCORDING TO SAM , the story of Sam Berns, a young boy with an extremely rare and highly-rapid aging disease called Progeria, and his family’€™s 13-year fight to find a cure. This film tells a story not only about the love of physician parents trying to save their son ’€“ it also portrays a winding journey throughout the scientific process and the pivotal role that medical innovation plays in our lives. In the film we see children with Progeria gather in Boston from around the world ’€“ all expected to live no longer than 13 years ’€“ to receive treatment and participate in a first-of-its-kind clinical trial. The film’€™s Oscar®-...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient